Tag: Hubert von Baumbach
“Patients in Europe do not want to be left behind”
Biotechnological Development Center Boehringer Ingelheim Julia Gueter is standing in a room with cell fermenters in the interdisciplinary development center for biotechnology of the pharmaceutical company Boehringer Ingelheim Pharma GmbH…
Diabetes drug ensures Boehringer’s growth leap
Frankfurt Strong growth in the diabetes drug Jardiance and positive currency effects brought the pharmaceutical company Boehringer Ingelheim 2022 the largest increase in sales in a good two decades. For…
New remedies for heart failure, cancer, schizophrenia
Frankfurt After several important advances in product development, the pharmaceutical group Boehringer Ingelheim sees itself at the beginning of a new investment offensive in the area of product development and…